newsfilter
← Latest News
GlobeNewswire·

Albireo to Report Q3 2022 Financial Results on November 8, 2022

BOSTON, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ:ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live